
Diagnostic Pathology: Thoracic, 3rd Edition
Hardcover

-
-
Provides a clear framework for a better understanding of the clinical and histopathologic appearances of pulmonary, pleural, and mediastinal entities
-
Features an updated chapter on severe acute respiratory syndrome (SARS) pneumonia with current knowledge, statistics, and pathophysiology on COVID-19, including new images that encompass the radiology, gross pathology, and histopathology of the disease
-
Includes updated criteria, terminology, and classifications for a wide range of tumors from the 2021 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus and Heart, reflecting changes to currently used terminologies for adenocarcinoma, squamous cell carcinoma, neuroendocrine tumors, mesothelioma, soft tissue tumors, benign tumors, and more
-
Covers the recent explosion of molecular genetic information, including new Molecular Pathology sections with new information on the genetic underpinnings of diseases
-
Specifies genetic mutation types associated with each tumor and covers numerous types of molecular tests, including next-generation sequencing studies and how the specific genetic alterations are used to differentiate disease and aid in diagnosis
-
Features over 3,900 high-quality images, including histologic images, gross pathology images, radiologic images, and full-color illustrations as well as more than 750 additional online-only images to help practicing and in-training pathologists reach a confident diagnosis
-
Contains multiple recent consensus clinical practice guidelines for thoracic disease diagnosis, including those for molecular genetic testing and predictive biomarker testing from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
-
Employs consistently templated chapters, bulleted content, key facts, and annotated images for quick, expert reference at the point of care
-
Includes the enhanced eBook version, which allows you to search all text, figures, and references on a variety of devices
-
-
SECTION 1: LUNG
NEOPLASMS, BENIGN
4 Congenital Peribronchial Myofibroblastic Tumor
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
6 Fetal Lung Interstitial Tumor
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
8 Mucous Gland Adenoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
12 Ciliated Muconodular Papillary Tumor
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
14 Alveolar Adenoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
18 Sclerosing Pneumocytoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
24 Cartilaginous Hamartoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
28 Endobronchial Lipoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
30 Pulmonary Adenofibroma/Adenomyoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
34 Glomus Tumor
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
36 Pulmonary Paraganglioma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
40 Pulmonary Meningioma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
44 Minute Pulmonary Meningothelial-Like Nodule
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
48 Granular Cell Tumor
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
50 Langerhans Cell Histiocytosis
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
54 Erdheim-Chester Disease
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
58 Clear Cell Sugar Tumor (PEComa)
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
62 Lymphangioleiomyomatosis
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
NEOPLASMS, MALIGNANT, PRIMARY
ADENOCARCINOMA
66 Overview of Malignant Epithelial Neoplasms of Lung
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
70 Conventional Adenocarcinoma
Mari Mino-Kenudson, MD, David I. Suster, MD, and Saul Suster, MD
82 Lepidic Predominant Adenocarcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
84 Invasive Mucinous Adenocarcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
88 Colloid Adenocarcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
92 Fetal Adenocarcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
96 Enteric-Type Adenocarcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
98 Other Adenocarcinoma Variants
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
102 Adenosquamous Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
SQUAMOUS CELL CARCINOMA
106 Conventional Squamous Cell Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
112 Basaloid/Small Cell Variant of Squamous Cell
Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
116 Lymphoepithelioma-Like Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul
Suster, MD
NEUROENDOCRINE CARCINOMA AND
PRECURSOR LESIONS
120 Overview of Neuroendocrine Neoplasms
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul
Suster, MD
124 Pulmonary Tumorlet and Diffuse Idiopathic
Pulmonary Neuroendocrine Cell Hyperplasia
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul
Suster, MD
126 Low-Grade Neuroendocrine Carcinoma (Typical
Carcinoid Tumor)
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul
Suster, MD
132 Intermediate-Grade Neuroendocrine Carcinoma
(Atypical Carcinoid Tumor)
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul
Suster, MD
136 High-Grade Neuroendocrine Carcinoma, Small Cell
Type
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul
Suster, MD
140 High-Grade Neuroendocrine Carcinoma, Large Cell
Type
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul
Suster, MD
POORLY DIFFERENTIATED NON-SMALL
CELL CARCINOMAS
144 Overview of Poorly Differentiated Non-Small Cell
Carcinomas
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
146 Large Cell Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
148 Pleomorphic Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
152 Spindle Cell Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
156 Carcinosarcoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
160 Pulmonary Blastoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
164 SMARCA4-Deficient Undifferentiated Tumors
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
168 NUT Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
SALIVARY GLAND-TYPE TUMORS
170 Adenoid Cystic Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
176 Mucoepidermoid Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
182 Epithelial-Myoepithelial Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
186 Acinic Cell Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
190 Mixed Tumor (Pleomorphic Adenoma)
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
194 Myoepithelial Carcinoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
MESENCHYMAL NEOPLASMS
198 Pleuropulmonary Blastoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
202 Primary Pulmonary Myxoid Sarcoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
204 Intrapulmonary Solitary Fibrous Tumor
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
208 Leiomyosarcoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
212 Intrapulmonary Synovial Sarcoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
218 Malignant Peripheral Nerve Sheath Tumor
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
222 Osteosarcoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD
226 Chondrosarcoma
David I. Suster, MD, Mari Mino-Kenudson, MD, and Saul Suster, MD